Serum Hepcidin-25 and Risk of Mortality in Patients on Peritoneal Dialysis

Frontiers in Medicine

Bin Li¹  Li Fan²  Dongying Fu²  Zhijian Li²  Zhong Zhong²  Wei Chen²  Dan Luo²  Ning Luo²  Haiping Mao² 

[1] Clinical Trials Unit, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China;Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China;Key Laboratory of Nephrology, National Health Commission and Guangdong Province, Guangzhou, China;

关键词: peritoneal dialysis;    serum hepcidin-25;    mortality;    cohort study;    prognostic factor;   

DOI  :  10.3389/fmed.2021.684548

来源: Frontiers

【 授权许可】

CC BY